- Home
- UNCY vs TOUR Comparison
UNCY vs TOUR Comparison
Compare UNCY & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- TOUR
- Stock Information
- Founded
- UNCY 2016
- TOUR 2006
- Country
- UNCY United States
- TOUR China
- Employees
- UNCY N/A
- TOUR N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- TOUR Transportation Services
- Sector
- UNCY Health Care
- TOUR Consumer Discretionary
- Exchange
- UNCY Nasdaq
- TOUR Nasdaq
- Market Cap
- UNCY 91.0M
- TOUR 101.0M
- IPO Year
- UNCY 2021
- TOUR 2014
- Fundamental
- Price
- UNCY $4.55
- TOUR $0.85
- Analyst Decision
- UNCY Strong Buy
- TOUR
- Analyst Count
- UNCY 4
- TOUR 0
- Target Price
- UNCY $63.75
- TOUR N/A
- AVG Volume (30 Days)
- UNCY 1.5M
- TOUR 236.8K
- Earning Date
- UNCY 08-13-2025
- TOUR 08-05-2025
- Dividend Yield
- UNCY N/A
- TOUR 4.36%
- EPS Growth
- UNCY N/A
- TOUR N/A
- EPS
- UNCY N/A
- TOUR 0.07
- Revenue
- UNCY N/A
- TOUR $72,098,119.00
- Revenue This Year
- UNCY N/A
- TOUR $16.99
- Revenue Next Year
- UNCY $1,458.53
- TOUR $13.23
- P/E Ratio
- UNCY N/A
- TOUR $12.32
- Revenue Growth
- UNCY N/A
- TOUR 7.64
- 52 Week Low
- UNCY $2.02
- TOUR $0.71
- 52 Week High
- UNCY $11.00
- TOUR $1.76
- Technical
- Relative Strength Index (RSI)
- UNCY 39.53
- TOUR 40.48
- Support Level
- UNCY $4.76
- TOUR $0.78
- Resistance Level
- UNCY $7.15
- TOUR $0.87
- Average True Range (ATR)
- UNCY 0.97
- TOUR 0.05
- MACD
- UNCY -0.28
- TOUR -0.00
- Stochastic Oscillator
- UNCY 7.37
- TOUR 30.57
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.